hereditary cancer
Foundation Medicine, Fulgent Genetics Partner to Launch Germline Testing in US
The Foundation Medicine next-generation sequencing-based panels use Fulgent's technology platform and will analyze genes associated with hereditary cancers.
NCCN Adds Prostate Cancer to Genetic Risk Assessment Guidelines
The NCCN also recently updated genetic risk guidelines for colorectal, endometrial, and gastric cancers.
Fulgent Genetics Wins VA Testing Contract Worth up to $99M
The agreement provides for up to $99 million for tests performed over a five-year period, ensuring access among the VA population.
Myriad Genetics, Flatiron Health Partner on EMR Integration of MyRisk Hereditary Cancer Test
The deal will allow doctors using Flatiron's cloud-based OncoEMR electronic medical record system to order Myriad's comprehensive cancer predisposition test.
ASCO Publishes Guidelines for Germline Testing in Solid Tumors
An expert panel has outlined which patients should get germline testing and which genes are most important to test across cancer types.
Nov 1, 2022